Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies - PubMed (original) (raw)

Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies

G M Steil et al. Diabetes. 1993 Feb.

Abstract

The FSIGT has been extensively applied to the minimal model of glucose kinetics to obtain noninvasive measures of Sl. The protocol has been modified by the addition of a bolus tolbutamide or insulin injection 20 min after glucose. Although the modified protocol has improved the Sl estimate, the method still requires a relatively large number of samples (n = 30). To reduce the total number of samples, we choose a sample schedule that minimizes the variance of the parameter estimates and the error in reconstructing the plasma insulin profile. With data from 10 subjects (BMI 30 +/- 7 kg/m2; Sl 0.9-10.2 x 10(-4) min-1.microU-1 x ml-1), a schedule consisting of 12 samples (0, 2, 4, 8, 19, 22, 30, 40, 50, 70, 90, and 180 min) was obtained. Estimates of Sl obtained from the reduced sampling schedule were then compared with those obtained with the full sampling schedule. In all 10 individuals, the Sl estimates were almost identical. A second, much larger data base consisting of 118 modified FSIGTs performed in 87 subjects (67 men, 20 women; BMI from 19.6 to 40 kg/m2 for men and 26.7 to 52.5 for women; Sl from 0.35 to 14.1 x 10(-4) min-1 x microU-1 x ml-1) was then used to independently assess the efficacy of the reduced sampling protocol. For this data base, the correlation between Sl, which was calculated from the full versus the reduced sampling schedule, was 0.95. The mean relative deviation was -1.5% (not significantly different from zero), and the SD of the relative deviation was 20.2%.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Cited by

The Subcutaneous Adipose Microenvironment as a Determinant of Body Fat Development in Polycystic Ovary Syndrome.
Dumesic DA, Rasouli MA, Katz JD, Lu GG, Dharanipragada D, Turcu AF, Grogan TR, Flores KE, Magyar CE, Abbott DH, Chazenbalk GD. Dumesic DA, et al. J Endocr Soc. 2024 Sep 17;8(11):bvae162. doi: 10.1210/jendso/bvae162. eCollection 2024 Sep 26. J Endocr Soc. 2024. PMID: 39345868 Free PMC article.
Methods for estimating insulin resistance from untargeted metabolomics data.
Hsu FC, Palmer ND, Chen SH, Ng MCY, Goodarzi MO, Rotter JI, Wagenknecht LE, Bancks MP, Bergman RN, Bowden DW. Hsu FC, et al. Metabolomics. 2023 Aug 9;19(8):72. doi: 10.1007/s11306-023-02035-5. Metabolomics. 2023. PMID: 37558891 Free PMC article.
Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.
Dumesic DA, Turcu AF, Liu H, Grogan TR, Abbott DH, Lu G, Dharanipragada D, Chazenbalk GD. Dumesic DA, et al. J Endocr Soc. 2023 Jun 7;7(8):bvad079. doi: 10.1210/jendso/bvad079. eCollection 2023 Jul 3. J Endocr Soc. 2023. PMID: 37404244 Free PMC article.
Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women.
Dumesic DA, Tulberg A, McNamara M, Grogan TR, Abbott DH, Naik R, Lu G, Chazenbalk GD. Dumesic DA, et al. J Endocr Soc. 2021 Oct 1;5(11):bvab158. doi: 10.1210/jendso/bvab158. eCollection 2021 Nov 1. J Endocr Soc. 2021. PMID: 34661039 Free PMC article.
Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
Dumesic DA, Tulberg A, Leung KL, Fisch SC, Grogan TR, Abbott DH, Naik R, Chazenbalk GD. Dumesic DA, et al. Fertil Steril. 2021 Jul;116(1):232-242. doi: 10.1016/j.fertnstert.2020.10.003. Epub 2020 Dec 17. Fertil Steril. 2021. PMID: 33341231 Free PMC article.

Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies - PubMed (original) (raw)